Maxime Veillette

1.9k total citations
20 papers, 833 citations indexed

About

Maxime Veillette is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Maxime Veillette has authored 20 papers receiving a total of 833 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Virology, 10 papers in Immunology and 9 papers in Infectious Diseases. Recurrent topics in Maxime Veillette's work include HIV Research and Treatment (16 papers), Immune Cell Function and Interaction (9 papers) and HIV/AIDS drug development and treatment (7 papers). Maxime Veillette is often cited by papers focused on HIV Research and Treatment (16 papers), Immune Cell Function and Interaction (9 papers) and HIV/AIDS drug development and treatment (7 papers). Maxime Veillette collaborates with scholars based in Canada, United States and Australia. Maxime Veillette's co-authors include Andrés Finzi, Mathieu Coutu, Daniel E. Kaufmann, Jonathan Richard, Michel Roger, George K. Lewis, Mattia Bonsignori, Cécile Tremblay, Nicole F. Bernard and Beatrice H. Hahn and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Journal of Virology.

In The Last Decade

Maxime Veillette

20 papers receiving 827 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maxime Veillette Canada 14 730 577 245 177 134 20 833
Ching-Lan Lu United States 6 690 0.9× 463 0.8× 369 1.5× 191 1.1× 169 1.3× 7 895
Mathieu Coutu Canada 14 715 1.0× 519 0.9× 265 1.1× 174 1.0× 102 0.8× 17 770
Matthew S. Parsons Australia 25 878 1.2× 1.1k 1.8× 290 1.2× 341 1.9× 315 2.4× 61 1.4k
Ariel Halper-Stromberg United States 8 889 1.2× 626 1.1× 360 1.5× 338 1.9× 190 1.4× 8 1.1k
Nirmin Alsahafi Canada 13 507 0.7× 314 0.5× 230 0.9× 86 0.5× 117 0.9× 13 584
Brigitte Boeser‐Nunnink Netherlands 18 692 0.9× 344 0.6× 395 1.6× 61 0.3× 206 1.5× 35 902
Fang-Hua Lee United States 13 624 0.9× 297 0.5× 372 1.5× 111 0.6× 104 0.8× 17 779
John Pietzsch United States 8 694 1.0× 681 1.2× 207 0.8× 434 2.5× 164 1.2× 8 1.1k
Leo Laub United States 4 570 0.8× 341 0.6× 222 0.9× 243 1.4× 149 1.1× 5 743
Gamze Isitman Australia 14 456 0.6× 649 1.1× 136 0.6× 192 1.1× 244 1.8× 20 828

Countries citing papers authored by Maxime Veillette

Since Specialization
Citations

This map shows the geographic impact of Maxime Veillette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxime Veillette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxime Veillette more than expected).

Fields of papers citing papers by Maxime Veillette

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxime Veillette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxime Veillette. The network helps show where Maxime Veillette may publish in the future.

Co-authorship network of co-authors of Maxime Veillette

This figure shows the co-authorship network connecting the top 25 collaborators of Maxime Veillette. A scholar is included among the top collaborators of Maxime Veillette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxime Veillette. Maxime Veillette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Veillette, Maxime, et al.. (2022). Clinical performance of SARS-CoV-2 detection on the cobas Liat using water gargle samples. SHILAP Revista de lepidopterología. 2(4). 100108–100108. 1 indexed citations
2.
Veillette, Maxime, Hubert Labelle, Jean‐Marc Mac‐Thiong, et al.. (2019). A Differential Hypofunctionality of Gαi Proteins Occurs in Adolescent Idiopathic Scoliosis and Correlates with the Risk of Disease Progression. Scientific Reports. 9(1). 10074–10074. 5 indexed citations
3.
Porichis, Filippos, Meghan G. Hart, Antigoni Morou, et al.. (2018). Immune Checkpoint Blockade Restores HIV-Specific CD4 T Cell Help for NK Cells. The Journal of Immunology. 201(3). 971–981. 48 indexed citations
4.
Prévost, Jérémie, Jonathan Richard, Maxime Veillette, et al.. (2017). Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses. Journal of Virology. 91(7). 35 indexed citations
5.
Demogines, Ann, Thomas Fricke, Mélodie B. Plourde, et al.. (2016). A putative SUMO interacting motif in the B30.2/SPRY domain of rhesus macaque TRIM5α important for NF-κB/AP-1 signaling and HIV-1 restriction. Heliyon. 2(1). e00056–e00056. 9 indexed citations
6.
Veillette, Maxime, Jérémie Prévost, Eric Sanders‐Buell, et al.. (2016). Histidine 375 Modulates CD4 Binding in HIV-1 CRF01_AE Envelope Glycoproteins. Journal of Virology. 91(4). 17 indexed citations
7.
Tolbert, William D., Neelakshi Gohain, Maxime Veillette, et al.. (2016). Paring Down HIV Env: Design and Crystal Structure of a Stabilized Inner Domain of HIV-1 gp120 Displaying a Major ADCC Target of the A32 Region. Structure. 24(5). 697–709. 43 indexed citations
8.
Veillette, Maxime, Jonathan Richard, Marzena Pazgier, et al.. (2015). Role of HIV-1 Envelope Glycoproteins Conformation and Accessory Proteins on ADCC Responses. Current HIV Research. 14(1). 9–23. 37 indexed citations
9.
Richard, Jonathan, Maxime Veillette, Shilei Ding, et al.. (2015). Small CD4 Mimetics Prevent HIV-1 Uninfected Bystander CD4 + T Cell Killing Mediated by Antibody-dependent Cell-mediated Cytotoxicity. EBioMedicine. 3. 122–134. 57 indexed citations
10.
Ding, Shilei, Maxime Veillette, Mathieu Coutu, et al.. (2015). A Highly Conserved Residue of the HIV-1 gp120 Inner Domain Is Important for Antibody-Dependent Cellular Cytotoxicity Responses Mediated by Anti-cluster A Antibodies. Journal of Virology. 90(4). 2127–2134. 58 indexed citations
11.
Veillette, Maxime, et al.. (2015). Preclinical Assessment of Mutant Human TRIM5α as an Anti-HIV-1 Transgene. Human Gene Therapy. 26(10). 664–679. 18 indexed citations
12.
Richard, Jonathan, Maxime Veillette, Annie‐Claude Labbé, et al.. (2014). Short Communication: Anti-HIV-1 Envelope Immunoglobulin Gs in Blood and Cervicovaginal Samples of Beninese Commercial Sex Workers. AIDS Research and Human Retroviruses. 30(11). 1145–1149. 19 indexed citations
13.
Veillette, Maxime, Mathieu Coutu, Jonathan Richard, et al.. (2014). Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay. Journal of Visualized Experiments. 6 indexed citations
14.
Richard, Jonathan, Maxime Veillette, Mathieu Coutu, et al.. (2014). Flow cytometry-based assay to study HIV-1 gp120 specific antibody-dependent cellular cytotoxicity responses. Journal of Virological Methods. 208. 107–114. 58 indexed citations
15.
Veillette, Maxime, Mathieu Coutu, Jonathan Richard, et al.. (2014). Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay. Journal of Visualized Experiments. 51995–51995. 33 indexed citations
16.
Veillette, Maxime, Mathieu Coutu, Jonathan Richard, et al.. (2014). The HIV-1 gp120 CD4-Bound Conformation Is Preferentially Targeted by Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies in Sera from HIV-1-Infected Individuals. Journal of Virology. 89(1). 545–551. 148 indexed citations
17.
Veillette, Maxime, Anik Désormeaux, Halima Medjahed, et al.. (2013). Interaction with Cellular CD4 Exposes HIV-1 Envelope Epitopes Targeted by Antibody-Dependent Cell-Mediated Cytotoxicity. Journal of Virology. 88(5). 2633–2644. 202 indexed citations
18.
Veillette, Maxime, et al.. (2013). A novel aminoacid determinant of HIV-1 restriction in the TRIM5α variable 1 region isolated in a random mutagenic screen. Virus Research. 173(2). 306–314. 9 indexed citations
19.
Veillette, Maxime, Paulina Pawlica, Stefan M.V. Freund, et al.. (2013). The V86M mutation in HIV-1 capsid confers resistance to TRIM5α by abrogation of cyclophilin A-dependent restriction and enhancement of viral nuclear import. Retrovirology. 10(1). 25–25. 26 indexed citations
20.
Buczinski, Sébastien, et al.. (2010). Echocardiographic findings in a goat with cor pulmonale secondary to chronic parasitic pneumonia. Schweizer Archiv für Tierheilkunde. 152(2). 81–85. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ching-Lan Lu Breakdown of academic impact, for papers by Mathieu Coutu Breakdown of academic impact, for papers by Matthew S. Parsons Breakdown of academic impact, for papers by Ariel Halper-Stromberg Breakdown of academic impact, for papers by Nirmin Alsahafi Breakdown of academic impact, for papers by Brigitte Boeser‐Nunnink Breakdown of academic impact, for papers by Fang-Hua Lee Breakdown of academic impact, for papers by John Pietzsch Breakdown of academic impact, for papers by Leo Laub Breakdown of academic impact, for papers by Gamze Isitman
Rankless by CCL
2026